Lite Strategy, Inc. (LITS)
0.9927
+0.01
(+0.73%)
USD |
NASDAQ |
Sep 01, 16:00
0.9927
0.00 (0.00%)
After-Hours: 18:59
Lite Strategy Net Income (TTM) : -60.82M for March 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -60.82M |
| December 31, 2025 | -39.70M |
| September 30, 2025 | -11.58M |
| June 30, 2025 | -15.94M |
| March 31, 2025 | -31.66M |
| December 31, 2024 | -38.22M |
| September 30, 2024 | -46.60M |
| June 30, 2024 | 17.78M |
| March 31, 2024 | 26.16M |
| December 31, 2023 | 19.84M |
| September 30, 2023 | 41.16M |
| June 30, 2023 | -31.84M |
| March 31, 2023 | -37.87M |
| December 31, 2022 | -31.16M |
| September 30, 2022 | -53.57M |
| June 30, 2022 | -54.45M |
| March 31, 2022 | -46.77M |
| December 31, 2021 | -63.67M |
| September 30, 2021 | -59.54M |
| June 30, 2021 | -44.12M |
| March 31, 2021 | -54.22M |
| December 31, 2020 | -32.92M |
| September 30, 2020 | -45.11M |
| June 30, 2020 | -46.02M |
| March 31, 2020 | -24.49M |
| Date | Value |
|---|---|
| December 31, 2019 | -37.51M |
| September 30, 2019 | -5.271M |
| June 30, 2019 | -16.82M |
| March 31, 2019 | -39.12M |
| December 31, 2018 | -27.72M |
| September 30, 2018 | -45.82M |
| June 30, 2018 | -40.07M |
| March 31, 2018 | -25.16M |
| December 31, 2017 | -19.81M |
| September 30, 2017 | -1.848M |
| June 30, 2017 | 2.67M |
| March 31, 2017 | 1.243M |
| December 31, 2016 | -3.526M |
| September 30, 2016 | -20.51M |
| June 30, 2016 | -20.86M |
| March 31, 2016 | -20.75M |
| December 31, 2015 | -24.31M |
| September 30, 2015 | -28.32M |
| June 30, 2015 | -32.69M |
| March 31, 2015 | -35.57M |
| December 31, 2014 | -34.03M |
| September 30, 2014 | -31.24M |
| June 30, 2014 | -27.15M |
| March 31, 2014 | -21.82M |
| December 31, 2013 | -17.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -32.46M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |